Prelude Capital Management’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-29,528
Closed -$326K 1380
2024
Q4
$326K Sell
29,528
-20,372
-41% -$225K 0.02% 662
2024
Q3
$613K Buy
+49,900
New +$613K 0.04% 474